ReviewOncotarget2018

Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development.

Debasis Patnaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.